New episode of #FDADirect just dropped and this one hits close to home—join us as we take a closer look at 🍞🥜🍤 and our food-safety priorities.

LIVE NOW “Expert Panels with the FDA” are a series of roundtable discussions to provide an open public discourse on the latest medical and scientific information on several important topics. Captioning available here: bit.ly/3SKW9HO x.com/i/broadcasts/1…

A new article from the U.S. FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach to such recommendations. Read the full article: nej.md/3F6EIhV #IDThreads

In our latest conversation, we’re talking COVID vaccine boosters and the framework for regulation for future approvals.

We should recommend a booster for healthy people in perpetuity? So that a young girl born today, in her average lifespan, will get 80 of these Covid boosters?

Today, the @WhitHouse, Donald J. Trump and Secretary Kennedy release a historic report on the childhood chronic disease crisis in America. "The report is the product of a consensual process, and it represents a collaborative effort of all the agencies and the White House. And it

Make Our Children Healthy Again! Read the full report: whitehouse.gov/maha/

Read the Make our Children Healthy Again Assessment, released today by the The White House: It’s a radically transparent analysis. whitehouse.gov/maha/

What a historic moment to witness stakeholders across #MAHA agencies from U.S. FDA to Dept. of Agriculture U.S. EPA discuss the #data behind the #rootcauses of America's health crisis. It's more than just our food, it's our environmental exposures, inactive lifestyle & system of overmedicalization

The FDA is conducting a national listening tour to meet directly with pharmaceutical and biotech CEOs. These forums are part of a new initiative to gather direct input from biotechnology and pharmaceutical leaders on how the FDA can modernize its regulatory framework to better

Our latest op-ed in The Wall Street Journal on the importance of evaluating talc. wsj.com/opinion/the-fd…

LIVE NOW: FDA Expert Panel on Infant Formula Captions available here: bit.ly/3SvT9z4 x.com/i/broadcasts/1…

Our latest FDA Direct discussion takes a deep dive into a recent COVID-19 vaccine marketing authorization.

Some takeaways from the past week ranging from Baby KJ to baby formula.

The new Huberman Lab episode is out: Improving Science & Restoring Trust in Public Health | Dr. Jay Bhattacharya (Jay Bhattacharya, MD, PhD) (0:00) Jay Bhattacharya (6:56) National Institutes of Health (NIH), Mission (9:12) Funding, Basic vs. Applied Research (18:22) Sponsors:

In the most recent JAMA, I outline our priorities for a new FDA, incorporating the two guiding principles of our philosophy: gold-standard science and common sense. jamanetwork.com/journals/jama/…

Committed to bringing more cures and meaningful treatments to the American public.

More about the Commissioner's National Priority Voucher Review pilot and how the FDA can reduce the time to review drug applications down to 1-2 months in The Washington Post washingtonpost.com/opinions/2025/…

We’re combining efficiency and gold-standard science to ensure the U.S. remains the global leader in advancing medical cures. Listen to the latest FDA Direct conversation where we discuss the Commissioner National Priority Voucher program. youtu.be/svqUa0jRXbY

This week we're talking about #medicaldevices and the intersection of consumer & health tech.